Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
44 studies found for:    Open Studies | "Meningitis"
Show Display Options
Rank Status Study
21 Not yet recruiting A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa
Condition: Infective Organism Causing Respiratory Diseaseand Meningitis
Intervention:
22 Recruiting Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)
Conditions: Meningitis;   Ventriculitis
Intervention: Drug: Ceftaroline fosamil
23 Recruiting A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Condition: Malaria
Interventions: Procedure: Lumbar puncture;   Procedure: Venous blood sample
24 Recruiting Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
25 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
26 Not yet recruiting Reduced PCV Dosing Schedules in South African Infants
Conditions: Pneumonia;   Meningitis
Interventions: Biological: Pneumococcal conjugate vaccine (PCV10 ) 1+1, 6 weeks;   Biological: Pneumococcal conjugate vaccine (PCV10 ) 1+1, 14 weeks;   Biological: Pneumococcal conjugate vaccine (PCV10 ) 2+1;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 1+1, 6 weeks;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 1+1, 14 weeks;   Biological: Pneumococcal conjugate vaccine (PCV13 ) 2+1
27 Recruiting Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
28 Recruiting Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free);   Biological: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)
29 Recruiting Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Conditions: Idiopathic CD4+ Lymphocytopenia;   Cryptococcal Meningitis;   Warts
Intervention:
30 Not yet recruiting Vietnam Cryptococcal Retention in Care Study
Conditions: Meningitis, Cryptococcal;   Central Nervous System Fungal Infections;   Central Nervous System Infections;   Meningitis, Fungal
Intervention: Drug: Fluconazole
31 Recruiting Early-Onset Sepsis an NICHD/CDC Surveillance Study
Conditions: Infant, Newborn, Diseases;   Early Onset Neonatal Sepsis;   Early-Onset Meningitis
Intervention:
32 Recruiting A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients
Conditions: Profound Bilateral Deafness Due to;   Bilateral Cochlear Aplasia;   Bilateral Cochlear Nerve Deficiency;   Bilateral Cochlear Ossification Secondary to Meningitis
Intervention: Device: Auditory Brainstem Implant
33 Recruiting Optimizing Treatment to Improve TBM Outcomes in Children
Condition: Tuberculosis, Meningeal
Interventions: Drug: High-dose: RIF, INH, PZA, EMB;   Drug: High dose: RIF, INH, PZA, LEVO;   Drug: Standard of care: RIF, INH, PZA, EMB
34 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Adenovirus;   Adrenal Insufficiency;   Airway Swelling;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Brain Swelling;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Edema;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Headaches;   Herpes Simplex Virus;   Hypertension;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Influenza;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Prophylaxis;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Stable Angina;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infection;   Withdrawal
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
35 Recruiting Fosfomycin i.v. for Treatment of Severely Infected Patients
Conditions: Bacterial Infections;   Bone Diseases, Infectious;   Osteomyelitis;   Central Nervous System Bacterial Infections;   Meningitis, Bacterial;   Encephalitis;   Brain Abscess;   Urinary Tract Infections;   Respiratory Tract Infections;   Pneumonia, Bacterial;   Skin Diseases, Bacterial;   Soft Tissue Infections;   Intraabdominal Infections;   Sepsis;   Bacteremia;   Endocarditis, Bacterial
Intervention:
36 Recruiting Hypovitaminosis D in Neurocritical Patients
Conditions: Craniocerebral Trauma;   Intracranial Aneurysm;   Brain Neoplasms;   Spinal Cord Injuries;   Seizures;   Meningitis;   Stroke;   Intracranial Hemorrhages;   Critical Illness;   Vitamin d Deficiency
Interventions: Drug: Cholecalciferol;   Other: Placebo
37 Recruiting Systematic Search for Primary Immunodeficiency in Adults With Infections
Conditions: Complement Deficiency;   Antibody Deficiency;   Chronic Sinus Infection;   Meningitis, Bacterial;   Pneumonia, Bacterial;   Otitis Media;   Streptococcal Infection;   Neisseria Infections;   Haemophilus Influenza;   Pneumococcal Infections
Intervention: Biological: Immunological diagnosis tests
38 Recruiting Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
Condition: Infections, Meningococcal
Interventions: Biological: Meningococcal ABCWY Vaccine;   Biological: Meningococcal B Recombinant vaccine
39 Recruiting Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo)
40 Recruiting Community Acquired Bacteremic Syndromes in Young Nigerian Children
Condition: Community-Acquired Infections
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.